ABSTRACT Arterial blood gas tensions were studied for six years in 85 patients (59 men, 26 women, mean age 58 8 years) with hypoxaemia associated with chronic bronchitis.
Hypoxaemia is a well-recognised feature of many patients with chronic obstructive bronchitis. When severe it is associated with recurrent attacks of ankle oedema and a poor prognosis; two-thirds of the patients dying within five years (Renzetti et al, 1966; Ude and Howard, 1971) . The natural history of hypoxaemia in obstructive airways disease has not been fully reported. In this study arterial blood gases and other parameters were measured at regular intervals in a group of patients attending a bronchitis clinic. The development of these physiological features has been related to the progress of the disease.
Patients and methods
Since 1972 all patients attending the bronchitis clinic who were judged to be centrally cyanosed by the colour of the tongue and who admitted to ankle oedema on at least one occasion were admitted to the study. Patients with good evidence of ischaemic heart disease clinically or electrocardiographically or with other identifiable causes of oedema were excluded, as were those who developed carcinoma of lung or died from causes other than respiratory failure. All patients had airways obstruction by spirometric tests. Most admitted to the production of sputum on most days, and all had breathlessness at least limiting their walking pace on the level.
Arterial blood samples were taken from the subjects while breathing air at outpatient examination at least once a year, and blood gas tensions were measured polarographically. Haematocrit, spirometry (Monaghan-Sandoz Ltd), and pulmonary artery pressure were measured while the subject was clinically stable at the beginning of the study. Pulmonary artery pressure, using thin polyethylene floating catheters inserted via a brachial vein were measured manometrically from a point level with the sternomanubrial junction and recorded by a Cambridge recorder (Pye Instruments). Haematocrit and spirometry were repeated whenever blood gas measurements were made. (Rotta et al, 1956 ) when subjects may live and work quite happily with a Pao2 around 7 kPa, but a few decompensate to enter a state of extreme hypoxaemia, drowsiness, and oedema (Monge's disease).
The development of hypoxaemia in individual patients reported in our study suggests that the phase of accelerated decline appears quite abruptly, and denotes real pathological change. There was no indication as to why this should occur as all other physiological measurements were unchanged. This finding has important implications for long-term oxygen treatment and raises several questions. Should treatment be started in the compensated phase to prevent the onset of accelerated decline? In the decompensated phase are the changes so entrenched as to be beyond the reach of treatment? Patients who died while on oxygen treatment declined at a rate similar to those who died without treatment. There was no indication from this study as to whether treatment in the phase of accelerated decline could return patients to the compensated stage. The current trials may shed more information on this point. This work was funded by a generous grant from the British Oxygen Corporation Ltd.
